Patents by Inventor Terry Raymond Beardsley

Terry Raymond Beardsley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method to treat inflammation
    Patent number: 8236323
    Abstract: The present invention relates generally to the fields of pharmacology, and particularly to a method for treating inflammation, particularly inflammation of the respiratory system. The invention provides a method to reduce or ameliorate inflammation, by administering an effective amount of a protein factor originally isolated from thymic tissue, and referred to as T4 immune stimulating factor (TISF).
    Type: Grant
    Filed: February 13, 2008
    Date of Patent: August 7, 2012
    Assignee: S-Cell Biosciences, Inc.
    Inventor: Terry Raymond Beardsley
  • METHOD TO ENHANCE HEMATOPOIESIS
    Publication number: 20110064691
    Abstract: The present invention relates generally to the fields of immunology and molecular biology, and particularly to a method for treating hematopoietic disorders. The invention provides a method to treat a deficiency of one or more types of blood cells in a mammal, which includes administering an effective amount of TISF or of a compound that stimulates CD4+ cells like TISF does. In one embodiment, TISF that originates from a mammalian species is administered to a mammalian subject diagnosed as having a deficiency in one or more types of blood cells.
    Type: Application
    Filed: November 23, 2010
    Publication date: March 17, 2011
    Applicant: S-Cell Biosciences, Inc.
    Inventors: Terry Raymond BEARDSLEY, Anthony E. Maida, III
  • Methods to treat T-cell disorders using TISF
    Patent number: 7776818
    Abstract: T4 Immune Stimulating Factor (TISF) selectively induces aberrant T-cells to initiate apoptosis. TISF and peptides that are related to TISF (TISF peptides) are therefore useful for the treatment of disorders characterized by aberrant production, development, or activity of T-cells or other cells of hematopoietic origin. This invention relates to methods of using TISF or a TISF peptide to treat such conditions, compositions containing TISF or a TISF peptide for use in such treatments, and use of TISF or a TISF peptide for the manufacture of pharmaceuticals.
    Type: Grant
    Filed: September 29, 2006
    Date of Patent: August 17, 2010
    Assignee: S-Cell Biosciences, Inc.
    Inventor: Terry Raymond Beardsley
  • METHOD TO TREAT INFLAMMATION
    Publication number: 20100144629
    Abstract: The present invention relates generally to the fields of pharmacology, and particularly to a method for treating inflammation, particularly inflammation of the respiratory system. The invention provides a method to reduce or ameliorate inflammation, by administering an effective amount of a protein factor originally isolated from thymic tissue, and referred to as T4 immune stimulating factor (TISF).
    Type: Application
    Filed: February 13, 2008
    Publication date: June 10, 2010
    Applicant: S-CELL BIOSCIENCES, INC.
    Inventor: Terry Raymond Beardsley
  • METHOD TO ENHANCE HEMATOPOIESIS
    Publication number: 20080267913
    Abstract: The present invention relates generally to the fields of immunology and molecular biology, and particularly to a method for treating hematopoietic disorders. The invention provides a method to treat a deficiency of one or more types of blood cells in a mammal, which includes administering an effective amount of TISF or of a compound that stimulates CD4+ cells like TISF does. In one embodiment, TISF that originates from a mammalian species is administered to a mammalian subject diagnosed as having a deficiency in one or more types of blood cells.
    Type: Application
    Filed: May 23, 2008
    Publication date: October 30, 2008
    Applicant: S-Cell Biosciences, Inc.
    Inventors: Terry Raymond Beardsley, Anthony E. Maida
  • Methods to treat T-cell disorders using TISF
    Publication number: 20070087968
    Abstract: T4 Immune Stimulating Factor (TISF) selectively induces aberrant T-cells to initiate apoptosis. TISF and peptides that are related to TISF (TISF peptides) are therefore useful for the treatment of disorders characterized by aberrant production, development, or activity of T-cells or other cells of hematopoietic origin. This invention relates to methods of using TISF or a TISF peptide to treat such conditions, compositions containing TISF or a TISF peptide for use in such treatments, and use of TISF or a TISF peptide for the manufacture of pharmaceuticals.
    Type: Application
    Filed: September 29, 2006
    Publication date: April 19, 2007
    Inventor: Terry Raymond Beardsley
  • Method to enhance hematopoiesis
    Patent number: 7196060
    Abstract: The present invention relates generally to the fields of immunology and molecular biology, and particularly to a method for treating hematopoietic disorders. The invention provides a method to treat a deficiency of one or more types of blood cells in a mammal, which includes administering an effective amount of TISF or of a compound that stimulates CD4+ cells like TISF does. In one embodiment, TISF that originates from a mammalian species is administered to a mammalian subject diagnosed as having a deficiency in one or more types of blood cells.
    Type: Grant
    Filed: September 10, 2004
    Date of Patent: March 27, 2007
    Assignee: S-Cell Biosciences, Inc.
    Inventors: Terry Raymond Beardsley, Anthony E. Maida, III